查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011735

CBD電子煙油市場：2026-2032年全球市場按產品類型、成分、口味類型、濃度和最終用戶進行預測。

CBD e-Liquids Market by Product Type, Composition, Flavor Type, Concentration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，CBD 電子煙油市場價值將達到 30.1 億美元，到 2026 年將成長至 34.1 億美元，到 2032 年將達到 76.7 億美元，複合年成長率為 14.29%。

主要市場統計數據
基準年 2025 30.1億美元
預計年份：2026年 34.1億美元
預測年份：2032年 76.7億美元
複合年成長率 (%) 14.29%

CBD電子煙油市場的市場動態和產業成熟度正在影響消費者信心、監管完整性和產品創新。

在法規結構不斷完善、產品創新層出不窮以及消費者偏好變化的推動下，CBD（大麻二酚）電子煙油市場在現代消費者和臨床健康領域的討論中日益受到重視。產業相關人員一直致力於改進提取方法、原料來源標籤和第三方檢測通訊協定，以滿足消費者對更高監管力度和透明度的需求。這些努力重建了製造商、零售商和終端用戶之間的信任，使零售商和專業經銷商能夠提供強調安全性、有效性和可追溯性的差異化提案。

法規的明確、消費者對高度透明配方的偏好以及分銷管道的演變正在重塑 CBD 電子煙油的競爭優勢。

在監管政策的明確性和產品創新的推動下，CBD電子煙油市場經歷了變革性的轉變，重新定義了競爭格局。消費者對潔淨標示和資訊完全揭露的需求，促使製造商致力於研發強調明確大麻素成分、標準化萜烯混合物以及減少對未公開添加劑依賴的配方。同時，健康訊息的傳播和作為成人尼古丁替代品的定位，正在擴大目標消費群體，促使製造商透過口味、濃度和給藥系統相容性來打造差異化的體驗。

為因應美國新的貿易措施，我們正在透過累積關稅來調整籌資策略、配方優先事項和供應鏈彈性措施。

2025年實施的累積關稅措施為全球供應鏈計算引入了新的變數，尤其對於途經複雜跨境貿易路線的原料、包裝材料和成品而言更是如此。從國際供應商採購大麻隔離群、植物性輔料或專有香精基質的製造商正面臨更高的收貨成本和更大的前置作業時間波動。因此，採購團隊正在重新審視其供應商組合，並加快向國內供應商和垂直整合合作夥伴多元化發展，以降低關稅波動帶來的風險。

詳細的細分分析揭示了產品類型、成分、口味、濃度和最終用戶特徵如何驅動產品組合差異化和通路策略。

細分市場分析揭示了微妙的需求模式，產業領導者可以利用這些模式來制定有針對性的產品策略。依產品類型分類，消費者的興趣可分為三類：頻譜CBD電子煙油、CBD隔離群電子煙油及全光譜CBD電子煙油。這些偏好受到感知功效、監管認可度和對微量大麻素接受度的影響。在許多市場，頻譜產品吸引了那些尋求多種大麻素協同作用且不含可檢測THC的消費者。另一方面，隔離群產品則受到那些優先考慮純度和明確劑量指南的消費者的青睞。全光譜產品在尋求最廣泛的大麻素和萜烯類化合物的用戶中保持著強勁的受歡迎程度，他們期待的是協同效應。

區域比較分析，重點在於世界不同地區的監管細分、零售業接受趨勢以及特定地區的市場准入要求。

美洲、歐洲、中東和非洲以及亞太地區的區域表現和戰略機會差異顯著，每個地區都呈現其獨特的監管、零售和消費行為環境。在美洲，多個司法管轄區的法規結構正逐步清晰化，明確了可接受的產品配方和零售通路。這促使現有的電子煙和健康產品零售商拓展產品線，並更加重視實驗室檢測保證和清晰的標籤。因此，能夠提供可靠的分析證書和符合監管規定的配方的品牌正迅速被主流零售市場所接受。

對品管系統、專有配方技術和經銷夥伴關係的投資如何改變 CBD 電子煙油公司的競爭地位？

CBD電子煙油市場的競爭格局由垂直整合型企業、專業配方生產商和以品牌驅動的創新者組成，這些企業專注於透過品質宣言、配方專業知識和分銷關係來實現差異化。主要企業正致力於投資分析實驗室、可追溯的採購通訊協定和可擴展的生產平台，以確保合規性並支援向實體店和電商通路的快速分銷。與原料供應商和配方開發商建立策略合作夥伴關係，透過實現可預測的大麻素成分和一致的感官特性，加速產品創新週期，最終提高零售商的接受度和消費者的複購率。

為確保永續競爭，我們正在實施切實可行的策略措施，以加強供應鏈韌性、監管合規性、產品組合清晰度和通路特定上市時間策略。

產業領導者必須採取果斷且切實可行的措施，將洞察轉化為永續的競爭優勢。首先，他們必須優先考慮供應鏈多元化，透過認證國內和區域關鍵原料供應商，並建立雙重前置作業時間體系，以降低關稅風險和交貨期中斷的影響。同時，他們必須加快配方最佳化計劃，尋找替代原料，在保持產品感官和功能特性的同時，減少對高風險供應商的依賴。這種雙管齊下的方法能夠增強企業韌性，並減少因價格突然上漲而可能損害消費者忠誠度的必要性。

調查方法結合了與關鍵相關人員的直接對話和輔助技術檢驗，為產業決策者提供了可操作的策略見解。

本執行摘要的研究結合了定性研究、定量資料整合以及透過二級資訊來源進行的嚴格檢驗，從而得出平衡且基於證據的結論。定性研究包括對來自製造和零售企業的監管專家、配方科學家、採購經理和高級商務主管進行結構化訪談，以了解他們應對監管變化和關稅趨勢的實際措施。這些訪談提供了對策略行動、供應鏈調整和產品開發重點的評估。

全面的策略洞察強調創新、監管合規和供應鏈柔軟性之間的平衡，這是確保在 CBD 電子煙油市場獲得長期競爭優勢所必需的。

總之，CBD電子煙油市場正處於轉折點，監管政策的明確性、供應鏈的韌性以及產品差異化將決定哪些公司能夠獲得長期價值。消費者對透明、高品質配方的需求與採購、檢測和合規等實際情況之間的相互作用，凸顯了研發、品質保證和商業性執行等環節整合能力的重要性。積極投資於可追溯採購、完善的檢測系統和靈活的產品系列結構的公司，更有可能應對關稅壓力和區域監管差異。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：CBD電子煙油市場：依產品類型分類

  • 頻譜CBD電子煙油
  • CBD隔離群電子煙油
  • 全光譜CBD電子煙油

第9章：CBD電子煙油市場：依成分分類

  • 非有機CBD電子煙油
  • 有機CBD電子煙油

第10章：CBD電子煙油市場：依口味分類

  • 飲料口味
  • 水果味
  • 薄荷醇口味
  • 甜味/甜點口味
  • 煙草味

第11章：CBD電子煙油市場：依濃度分類

  • 高濃度（超過 500 毫克）
  • 低濃度（250毫克或更少）
  • 中等濃度（250毫克至500毫克）

第12章：CBD電子煙油市場：依終端使用者分類

  • 醫療用途
  • 僅供娛樂

第13章：CBD電子煙油市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：CBD電子煙油市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：CBD電子煙油市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國CBD電子煙油市場

第17章：中國CBD電子煙油市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avida CBD
  • CBD American Shaman
  • CBDfx
  • CBDistillery
  • cbdMD
  • Charlotte's Web, Inc.
  • Extract Labs
  • Five CBD
  • Green Roads
  • Hemp Bombs
  • HempLucid
  • Joy Organics
  • JustCBD
  • KIND Concentrates
  • Koi CBD
  • Medterra
  • Naked 100
  • PureKana
  • Select Oil
  • VSAVI
Product Code: MRR-430D3EB72361

The CBD e-Liquids Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.41 billion in 2026, with a CAGR of 14.29%, reaching USD 7.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.41 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 14.29%

Market dynamics and industry maturation shaping consumer confidence, regulatory alignment, and product innovation across the CBD e-liquids landscape

The cannabidiol (CBD) e-liquids segment occupies an increasingly prominent position in contemporary consumer and clinical wellness conversations, driven by evolving regulatory frameworks, product innovation, and shifting consumer preferences. Industry participants have responded to heightened regulatory scrutiny and consumer demand for transparency by refining extraction methods, ingredient provenance claims, and third-party testing protocols. These efforts have helped rebalance trust dynamics between manufacturers, retailers, and end users, enabling retailers and specialized distributors to present differentiated propositions that emphasize safety, efficacy, and traceability.

Moreover, technological advances in formulation science, including improved solventless extraction techniques and standardized cannabinoid profiling, have enabled a broader array of product formats and concentration options. Concurrently, retail channels have diversified: traditional vape retailers coexist with lifestyle stores, online specialists, and health-focused outlets, each applying distinct compliance and merchandising approaches. As a result, stakeholders must calibrate product development, labeling, and education initiatives to align with both evolving regulation and the nuanced preferences of medical and recreational users, while ensuring supply chain transparency and ingredient integrity across the value chain.

Shifts in regulatory clarity, consumer preference for transparent formulations, and distribution channel evolution reshaping competitive advantage in CBD e-liquids

The CBD e-liquids landscape has undergone transformative shifts that have redefined competitive dynamics, with regulatory clarity and product innovation at the forefront. Consumer demand for cleaner label claims and full disclosure has driven manufacturers toward formulations emphasizing defined cannabinoid profiles, standardized terpene blends, and reduced reliance on undisclosed additives. At the same time, the convergence of wellness narratives and adult nicotine-alternative positioning has expanded the addressable consumer set, prompting producers to design differentiated experiences through flavor, concentration, and delivery system compatibility.

Transitioning distribution channels have had a catalytic effect. Retailers and digital platforms increasingly enforce rigorous proof-of-compliance standards, and strategic partnerships between ingredient suppliers and formulators have shortened innovation cycles. In parallel, vertical integration strategies-where extraction, formulation, and packaging operations co-locate-have emerged to control quality and margin pressure. These shifts collectively favor manufacturers that can demonstrate consistent analytical data, scalable production practices, and rapid go-to-market capability while navigating a regulatory environment that demands evidence of safety and accurate labeling.

Cumulative tariff-induced adjustments to sourcing strategies, formulation priorities, and supply chain resilience measures in response to new United States trade measures

The introduction of cumulative tariff measures in the United States in 2025 has introduced new variables into global supply chain calculus, particularly for ingredients, packaging components, and finished formulations that traverse complex cross-border trade routes. Manufacturers that source cannabis-derived isolates, botanical co-ingredients, or proprietary flavor matrices from international suppliers have faced elevated landed costs and increased lead-time variability. Consequently, procurement teams have reassessed supplier portfolios, accelerating diversification toward domestic suppliers or vertically integrated partners to reduce exposure to tariff volatility.

Furthermore, the tariff environment has intensified cost-transparency scrutiny across commercial teams, with pricing strategies adapting to preserve retail competitiveness without sacrificing compliance or testing rigor. This has led to an uptick in formulation engineers exploring ingredient substitutions that maintain sensory and functional characteristics while optimizing supply chain resilience. In addition, compliance teams have deepened customs and regulatory expertise to navigate classification, preferential origin claims, and duty mitigation pathways. Collectively, these responses underscore that tariffs have not only affected unit economics but have also prompted strategic shifts in sourcing, R&D priorities, and channel deployment plans.

Detailed segmentation insights revealing how product type, composition, flavor profiles, concentrations, and end-user distinctions drive portfolio differentiation and channel strategy

Segmentation analysis reveals nuanced demand patterns that industry leaders can leverage for targeted product strategies. Based on product type, consumer interest bifurcates between Broad-Spectrum CBD E-Liquids, CBD Isolate E-Liquids, and Full-Spectrum CBD E-Liquids, where preference trends are influenced by perceptions of efficacy, regulatory acceptance, and tolerance for trace cannabinoids. In many markets, broad-spectrum options attract consumers seeking multi-cannabinoid synergy without detectable THC, whereas isolate formats appeal to those prioritizing purity and straightforward dosing guidance. Full-spectrum formulations maintain traction among users seeking the widest cannabinoid and terpene complexity for perceived entourage benefits.

Based on composition, demand splits between Non-Organic CBD E-Liquids and Organic CBD E-Liquids, with organic credentials commanding a price premium among health-conscious consumers and retail partners focused on natural product assortments. Based on flavor type, product portfolios must accommodate Beverage Flavored, Fruit Flavored, Menthol/Mint Flavored, Sweet/Dessert Flavored, and Tobacco Flavored preferences, as taste profiles act as critical purchase drivers that vary by demographic and by channel. Based on concentration, manufacturers must offer High Concentration (above 500 mg), Low Concentration (up to 250 mg), and Medium Concentration (250 mg - 500 mg) options to satisfy both novice users seeking low-dose introductions and experienced users requiring higher-dosage formulations. Finally, based on end user, the distinction between Medical Use and Recreational Use influences labeling, claims, and distribution, with medical channels prioritizing standardized dosing and clinical evidence while recreational channels emphasize sensory experience and lifestyle positioning.

These segmentation insights indicate that winning portfolios will balance purity credentials, flavor innovation, and concentration breadth, while aligning distribution and communication strategies to the distinct expectations of medical and recreational end users.

Comparative regional analysis highlighting regulatory fragmentation, retail acceptance dynamics, and localized go-to-market requirements across global regions

Regional performance and strategic opportunity vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct regulatory, retail, and consumer behavior contexts. In the Americas, regulatory frameworks in several jurisdictions have progressively clarified permissible product formulations and retail channels, encouraging established vape and wellness retailers to expand assortments that emphasize lab-tested assurances and clear labeling. Consequently, brands that can supply robust analytical certificates and compliant formulations find accelerated acceptance in mainstream retail environments.

In Europe, Middle East & Africa, regulatory fragmentation persists, with country-level variations in permissible cannabinoid content and claims driving a patchwork of compliance requirements. Consequently, regional distributors and multinational brands prioritize adaptable formulations and modular labeling systems to meet disparate legal regimes. In Asia-Pacific, regulatory conservatism in many markets constrains broader retail availability, but pockets of permissive policy and high consumer interest in wellness innovations have created premium niches. In such jurisdictions, partnerships with local regulatory and distribution specialists prove essential. Across regions, consumer education initiatives, rigorous testing, and transparent supply chain storytelling consistently emerge as cross-regional enablers of consumer trust and retailer adoption.

How investment in quality systems, proprietary formulation assets, and distribution partnerships is reshaping competitive positioning among CBD e-liquids companies

Competitive dynamics in the CBD e-liquids landscape are shaped by a mix of vertically integrated players, specialized formulators, and branded innovators focused on differentiation through quality claims, formulation expertise, and distribution relationships. Leading companies concentrate investments in analytical laboratories, traceable sourcing protocols, and scalable production platforms to maintain compliance and support rapid distribution to both brick-and-mortar and e-commerce channels. Strategic partnerships between ingredient suppliers and formulators accelerate product innovation cycles by enabling predictable cannabinoid profiles and consistent sensorial outcomes, which in turn facilitate retailer onboarding and consumer repeat purchase.

Additionally, intellectual property around flavor systems and delivery technology has emerged as a non-price lever for competitive advantage. Companies that secure proprietary terpene blends or optimized carrier matrices can command stronger brand loyalty and defend margin through perceived product superiority. Corporate investment patterns also indicate prioritization of regulatory affairs capabilities and quality management systems to navigate evolving testing requirements and to mitigate recall risk. In aggregate, these company-level moves favor organizations that integrate quality assurance, R&D, and flexible manufacturing to serve diverse channel needs while preserving regulatory integrity.

Practical strategic actions to fortify supply chain resilience, regulatory compliance, portfolio clarity, and channel-specific go-to-market execution for sustained competitiveness

Industry leaders must take decisive, actionable steps to translate insight into durable advantage. First, prioritize supply chain diversification by qualifying domestic and regional suppliers for critical inputs, and establish dual-sourcing arrangements to mitigate tariff exposure and lead-time disruption. Simultaneously, accelerate formulation optimization programs that identify ingredient alternatives capable of preserving sensory and functional characteristics while lowering dependence on high-risk suppliers. This two-pronged approach enhances resilience and reduces the need for abrupt price increases that could erode consumer loyalty.

Second, strengthen regulatory and quality infrastructure by expanding third-party testing partnerships, publishing transparent certificates of analysis, and investing in robust labeling systems that can adapt across jurisdictions. Third, refine portfolio architecture to match segmentation demands: ensure offerings span broad-spectrum, isolate, and full-spectrum formulations; provide organic options; deliver a coherent flavor roster across beverage, fruit, menthol/mint, sweet/dessert, and tobacco profiles; and maintain a calibrated concentration ladder from low to high strength to serve both medical and recreational consumers. Finally, deepen channel-specific go-to-market tactics by deploying educational content for medical channels while emphasizing lifestyle and sensory communication in recreational outlets. Taken together, these actions reduce operational risk and enhance perceived product integrity among retailers and consumers.

Methodological approach combining primary stakeholder engagement and secondary technical validation to produce actionable strategic intelligence for industry decision-makers

The research underpinning this executive summary blended primary qualitative engagements with quantitative data synthesis and rigorous secondary-source validation to ensure balanced, evidence-based conclusions. Primary research included structured interviews with regulatory specialists, formulation scientists, procurement leaders, and senior commercial executives across manufacturing and retail organizations to capture operational responses to regulatory changes and tariff dynamics. These conversations informed the assessment of strategic behavior, supply chain adjustments, and product development priorities.

Secondary analysis incorporated a wide range of publicly available regulatory guidance, technical white papers, and peer-reviewed studies on cannabinoid chemistry, inhalation safety, and flavor systems to corroborate practitioner insights. Additionally, cross-validation of supplier capabilities and manufacturing trends relied on industry disclosures and product specification documentation. Throughout the research process, emphasis was placed on triangulating data sources to reconcile differences between stated intent and operational practice, ensuring that findings reflect implementable strategic implications rather than aspirational statements alone.

Summative strategic implications emphasizing the balance of innovation, regulatory compliance, and supply chain flexibility required to secure long-term advantage in CBD e-liquids

In conclusion, the CBD e-liquids category stands at an inflection point where regulatory clarity, supply chain resilience, and product differentiation will determine which companies capture long-term value. The interplay between consumer demand for transparent, high-quality formulations and the operational realities of sourcing, testing, and compliance has elevated the importance of integrated capabilities spanning R&D, quality assurance, and commercial execution. Organizations that invest proactively in traceable sourcing, robust testing regimes, and adaptable portfolio structures will be better positioned to navigate tariff pressures and regional regulatory divergence.

Looking ahead, success will hinge on the ability to balance innovation with conservative risk management. By aligning product offerings with clearly defined end-user needs, maintaining rigorous analytical standards, and constructing flexible supply chains, companies can both reduce vulnerability to external shocks and create compelling propositions for a diverse set of retail and medical channels. The strategic choices made in the near term will shape competitive trajectories and determine which organizations convert current disruption into sustained marketplace advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. CBD e-Liquids Market, by Product Type

  • 8.1. Broad-Spectrum CBD E-Liquids
  • 8.2. CBD Isolate E-Liquids
  • 8.3. Full-Spectrum CBD E-Liquids

9. CBD e-Liquids Market, by Composition

  • 9.1. Non-Organic CBD E-Liquids
  • 9.2. Organic CBD E-Liquids

10. CBD e-Liquids Market, by Flavor Type

  • 10.1. Beverage Flavored
  • 10.2. Fruit Flavored
  • 10.3. Menthol/Mint Flavored
  • 10.4. Sweet/Dessert Flavored
  • 10.5. Tobacco Flavored

11. CBD e-Liquids Market, by Concentration

  • 11.1. High Concentration (above 500 mg)
  • 11.2. Low Concentration (up to 250 mg)
  • 11.3. Medium Concentration (250 mg - 500 mg)

12. CBD e-Liquids Market, by End User

  • 12.1. Medical Use
  • 12.2. Recreational Use

13. CBD e-Liquids Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. CBD e-Liquids Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. CBD e-Liquids Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States CBD e-Liquids Market

17. China CBD e-Liquids Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Avida CBD
  • 18.6. CBD American Shaman
  • 18.7. CBDfx
  • 18.8. CBDistillery
  • 18.9. cbdMD
  • 18.10. Charlotte's Web, Inc.
  • 18.11. Extract Labs
  • 18.12. Five CBD
  • 18.13. Green Roads
  • 18.14. Hemp Bombs
  • 18.15. HempLucid
  • 18.16. Joy Organics
  • 18.17. JustCBD
  • 18.18. K.I.N.D. Concentrates
  • 18.19. Koi CBD
  • 18.20. Medterra
  • 18.21. Naked 100
  • 18.22. PureKana
  • 18.23. Select Oil
  • 18.24. VSAVI

LIST OF FIGURES

  • FIGURE 1. GLOBAL CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CBD E-LIQUIDS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CBD E-LIQUIDS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BROAD-SPECTRUM CBD E-LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BROAD-SPECTRUM CBD E-LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BROAD-SPECTRUM CBD E-LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY CBD ISOLATE E-LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY CBD ISOLATE E-LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY CBD ISOLATE E-LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FULL-SPECTRUM CBD E-LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FULL-SPECTRUM CBD E-LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FULL-SPECTRUM CBD E-LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY NON-ORGANIC CBD E-LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY NON-ORGANIC CBD E-LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY NON-ORGANIC CBD E-LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY ORGANIC CBD E-LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY ORGANIC CBD E-LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY ORGANIC CBD E-LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BEVERAGE FLAVORED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BEVERAGE FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY BEVERAGE FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FRUIT FLAVORED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FRUIT FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY FRUIT FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MENTHOL/MINT FLAVORED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MENTHOL/MINT FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MENTHOL/MINT FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY SWEET/DESSERT FLAVORED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY SWEET/DESSERT FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY SWEET/DESSERT FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY TOBACCO FLAVORED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY TOBACCO FLAVORED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY TOBACCO FLAVORED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY HIGH CONCENTRATION (ABOVE 500 MG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY HIGH CONCENTRATION (ABOVE 500 MG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY HIGH CONCENTRATION (ABOVE 500 MG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY LOW CONCENTRATION (UP TO 250 MG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY LOW CONCENTRATION (UP TO 250 MG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY LOW CONCENTRATION (UP TO 250 MG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDIUM CONCENTRATION (250 MG - 500 MG), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDIUM CONCENTRATION (250 MG - 500 MG), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDIUM CONCENTRATION (250 MG - 500 MG), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDICAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY MEDICAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY RECREATIONAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY RECREATIONAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY RECREATIONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 111. GCC CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 129. G7 CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 135. NATO CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CBD E-LIQUIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA CBD E-LIQUIDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA CBD E-LIQUIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA CBD E-LIQUIDS MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA CBD E-LIQUIDS MARKET SIZE, BY FLAVOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA CBD E-LIQUIDS MARKET SIZE, BY CONCENTRATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA CBD E-LIQUIDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)